ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
綠竹生物-B
21.000
+0.350
1.69%
手動刷新
成交量:
5.24萬
成交額:
122.89萬
市值:
41.79億
市盈率:
-23.24
高:
25.000
開:
21.600
低:
21.000
收:
20.650
資料載入中...
總覽
公司
新聞
公告
港股生物醫藥股集體走強,綠竹生物-B漲超10%
老虎资讯综合
·
昨天
綠竹生物-B(02480)股價大幅上升16.279%,現價港幣$25.0
阿斯达克财经
·
05-15
綠竹生物-B盤中異動 股價大漲6.51%
市场透视
·
05-15
綠竹生物-B(02480)出現大手成交220萬股,成交價$22.0,涉資4.84千萬
阿斯达克财经
·
05-09
綠竹生物-B盤中異動 急速下挫5.68%報20.750港元
市场透视
·
05-08
核心帶皰疫苗或在明年上市,能否將綠竹生物-B(02480)拖出“流動性陷阱”?
智通财经
·
05-07
綠竹生物-B盤中異動 股價大跌7.95%報20.250港元
市场透视
·
05-06
綠竹生物-B(02480)5月2日斥資3971.33萬港元回購175.92萬股
智通财经
·
05-02
綠竹生物-B股價重挫10.20% 市值跌4.51億港元
市场透视
·
04-30
綠竹生物-B:核心產品重組帶狀皰疹疫苗LZ901上市申請獲受理
国信证券
·
04-21
綠竹生物-B(02480)提名孔健為第五屆董事會執行董事候選人
智通财经
·
04-16
綠竹生物-B(02480)出現大手買入40萬股,成交價$24.85,涉資994萬
阿斯达克财经
·
04-03
【券商聚焦】建銀國際維持綠竹生物(02480)跑贏大市評級 指其2024年全年業績超預期
金吾财讯
·
03-20
綠竹生物-B公佈年度業績:虧損同比收窄32.5%,繼續專注於核心產品LZ901的研發工作
格隆汇
·
03-18
綠竹生物-B(02480)發佈年度業績,稅前虧損1.68億元 同比減少32.5%
智通财经
·
03-18
綠竹生物-B03月14日主力淨流入49萬元 散戶資金拋售
市场透视
·
03-14
綠竹生物-B盤中異動 下午盤大幅上漲7.54%
市场透视
·
03-14
綠竹生物-B盤中異動 大幅下跌7.58%報22.550港元
市场透视
·
03-13
綠竹生物-B盤中異動 快速下跌8.85%
市场透视
·
03-12
綠竹生物-B03月11日主力淨流入19萬元 散戶資金拋售
市场透视
·
03-11
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02480/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02480","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02480\",,,,,undefined,":{"symbol":"02480","market":"HK","secType":"STK","nameCN":"綠竹生物-B","latestPrice":21,"timestamp":1747382900032,"preClose":20.65,"halted":0,"volume":52400,"delay":0,"floatShares":199000000,"shares":199000000,"eps":-0.903589089417299,"marketStatus":"休市中","change":0.35,"latestTime":"05-16 16:08:20","open":21.6,"high":25,"low":21,"amount":1228940,"amplitude":0.193705,"askPrice":22.8,"askSize":200,"bidPrice":21,"bidSize":1400,"shortable":3,"etf":0,"ttmEps":-0.903589089417299,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747618200000},"marketStatusCode":7,"adr":0,"listingDate":1683475200000,"exchange":"SEHK","adjPreClose":20.65,"openAndCloseTimeList":[[1747359000000,1747368000000],[1747371600000,1747382400000]],"volumeRatio":0.08702584200605634,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02480\",,,,,undefined,":{"symbol":"02480","floatShares":199000000,"roa":"-11.31%","roe":"-17.95%","lyrEps":-0.903589,"volumeRatio":0.08702584200605634,"shares":199000000,"dividePrice":0,"high":25,"amplitude":0.193705,"preClose":20.65,"low":21,"week52Low":19,"pbRate":"4.52","week52High":27.2,"institutionHeld":0,"latestPrice":21,"committee":0.75,"eps":-0.903589089417299,"divideRate":0,"volume":52400,"delay":0,"ttmEps":-0.903589089417299,"open":21.6,"prevYearClose":22.95,"prevWeekClose":21.4,"prevMonthClose":24.2,"prevQuarterClose":24.85,"fiveDayClose":21.4,"twentyDayClose":24.65,"sixtyDayClose":21.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02480\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1187897028","title":"港股生物醫藥股集體走強,綠竹生物-B漲超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187897028","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187897028?lang=zh_tw&edition=fundamental","pubTime":"2025-05-16 09:37","pubTimestamp":1747359426,"startTime":"0","endTime":"0","summary":"5月16日,港股生物医药股集体走强,$绿竹生物-B(02480)$、$北海康成-B(01228)$涨超10%,$中国抗体-B(03681)$涨超7%,$再鼎医药(09688)$、$康希诺生物(06185)$涨近4%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b136a5dcc9908cfc39153f845e631c9a","theme_name":"🔥熱榜No.27 · 港股生物醫藥股集體走強,中國抗體-B股價飆升10.16%","theme_type":2,"isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","07226","BK1161","BK4531","BK4585","BK1515","BK4526","01228","HSTECH","BK1588","BK4614","02480","BK4588","BK4548","ZLAB","LU2488822045.USD","YANG","09688","03681","06185"],"gpt_icon":0},{"id":"2535949865","title":"綠竹生物-B(02480)股價大幅上升16.279%,現價港幣$25.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2535949865","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535949865?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 13:34","pubTimestamp":1747287240,"startTime":"0","endTime":"0","summary":"[上升股]绿竹生物-B(02480) 股价在下午01:34比前收市价大幅上升16.279%,现股价为港币$25.0。至目前为止,今日最高价为$25.0,而最低价为$22.0。总成交量为1.02万股,总成交金额为港币$23.085万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2505151476/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2535868244","title":"綠竹生物-B盤中異動 股價大漲6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535868244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535868244?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 13:15","pubTimestamp":1747286142,"startTime":"0","endTime":"0","summary":"2025年05月15日下午盘13时15分,绿竹生物-B股票出现波动,股价急速上涨6.51%。截至发稿,该股报22.900港元/股,成交量7400股,换手率0.00%,振幅4.19%。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.81%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515131542aa2c8f62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515131542aa2c8f62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2534519012","title":"綠竹生物-B(02480)出現大手成交220萬股,成交價$22.0,涉資4.84千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2534519012","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534519012?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 09:03","pubTimestamp":1746752580,"startTime":"0","endTime":"0","summary":"[大手成交]绿竹生物-B(02480)在上午09:03出现大手成交,成交量为220万,成交价为港币$22.0,涉资4.84千万。至目前为止,股价无升跌,今日最高价为$22.0,而最低价为$22.0,总成交量为298.64万股,总成交金额港币$6.57千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2505092/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2533914702","title":"綠竹生物-B盤中異動 急速下挫5.68%報20.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533914702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533914702?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 10:31","pubTimestamp":1746671484,"startTime":"0","endTime":"0","summary":"2025年05月08日早盘10时31分,绿竹生物-B股票出现波动,股价急速下挫5.68%。截至发稿,该股报20.750港元/股,成交量200股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出4150港元。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.06%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。对此,百克生物表示,主要系本报告期带状疱疹疫苗销量减少所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508103125aa2c86c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508103125aa2c86c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2533616225","title":"核心帶皰疫苗或在明年上市,能否將綠竹生物-B(02480)拖出“流動性陷阱”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2533616225","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533616225?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 09:29","pubTimestamp":1746581356,"startTime":"0","endTime":"0","summary":"对此,百克生物表示,主要系本报告期带状疱疹疫苗销量减少所致。然而,受到百克生物此次年报业绩表现打击最大的似乎并非百克本身,而是尚未实现产品收入且核心带疱疫苗即将上市的绿竹生物-B。今年一季度,国内疫苗行业上市公司似乎集体遭遇了“滑铁卢”。回到带疱疫苗,其实目前市场竞争环境良好,因为仅有百克生物的感维和GSK的Shingrix上市,如果绿竹生物的LZ901能够按预期的2026年上半年前后商业化,便可成为国内第三款带疱疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161","159646"],"gpt_icon":0},{"id":"2533542602","title":"綠竹生物-B盤中異動 股價大跌7.95%報20.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533542602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533542602?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 09:48","pubTimestamp":1746496126,"startTime":"0","endTime":"0","summary":"2025年05月06日早盘09时48分,绿竹生物-B股票出现波动,股价大幅下跌7.95%。截至发稿,该股报20.250港元/股,成交量1200股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出2.43万港元。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.54%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050609484694ed618f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050609484694ed618f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2532481468","title":"綠竹生物-B(02480)5月2日斥資3971.33萬港元回購175.92萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2532481468","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532481468?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 18:51","pubTimestamp":1746183090,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿竹生物-B(02480)发布公告,于2025年5月2日斥资3971.33万港元回购股份175.92万股,每股回购价格为21.95-23港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2531772732","title":"綠竹生物-B股價重挫10.20% 市值跌4.51億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531772732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531772732?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 14:15","pubTimestamp":1745993720,"startTime":"0","endTime":"0","summary":"2025年04月30日下午盘14时15分,绿竹生物-B股票出现波动,股价快速跳水10.20%。截至发稿,该股报22.000港元/股,成交量800股,换手率0.00%,振幅10.00%。资金方面,该股资金流入1.831万港元,流出0港元。绿竹生物-B股票所在的生物技术行业中,整体涨幅为1.70%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043014152094e88a81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043014152094e88a81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2529177338","title":"綠竹生物-B:核心產品重組帶狀皰疹疫苗LZ901上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2529177338","media":"国信证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529177338?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 00:00","pubTimestamp":1745164800,"startTime":"0","endTime":"0","summary":"投资建议:公司核心品种重组带状疱疹疫苗LZ901 采用创新抗原设计,诱导高水平体液及细胞免疫应答的同时,兼具较好的安全性;LZ901 已提交上市申请并获受理,预计将于2026H1 实现产品商业化,考虑到国内疫苗新产品一般需要3~6 个月进行省级招标准入,我们预计LZ901 将于2026H2 开始贡献收入增量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421112124a6c1c53f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421112124a6c1c53f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2527760249","title":"綠竹生物-B(02480)提名孔健為第五屆董事會執行董事候選人","url":"https://stock-news.laohu8.com/highlight/detail?id=2527760249","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527760249?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 21:47","pubTimestamp":1744811272,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿竹生物-B(02480)发布公告,经考虑董事会提名委员会的推荐建议,董事会决议提名孔健、张琰平及彭玲为第五届董事会执行董事候选人;马骉及孔双泉为第五届董事会非执行董事候选人;以及梁伟业、梁冶矢及侯爱军为第五届董事会独立非执行董事候选人(统称董事候选人)。除拟接替蒋先敏的候选人彭玲(其现担任公司监事兼首席技术官)外,各董事候选人均为现任董事。公司第四届监事会的任期将于2025年9月15日届满,而董事会及监事会均已决议提名现任监事孔茜为第五届监事会股东代表监事候选人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279775.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2524422260","title":"綠竹生物-B(02480)出現大手買入40萬股,成交價$24.85,涉資994萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2524422260","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524422260?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 09:00","pubTimestamp":1743642000,"startTime":"0","endTime":"0","summary":"[大手成交]绿竹生物-B(02480)在上午09:00出现大手买入,成交量为40万,成交价为港币$24.85,涉资994万。至目前为止,股价无升跌,今日最高价为$24.85,而最低价为$24.85,总成交量为40万股,总成交金额港币$994万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2504031/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2520265791","title":"【券商聚焦】建銀國際維持綠竹生物(02480)跑贏大市評級 指其2024年全年業績超預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2520265791","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520265791?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 11:14","pubTimestamp":1742440448,"startTime":"0","endTime":"0","summary":"金吾财讯 | 建银国际发研报指,绿竹生物 2024年下半年/2024年全年业绩超预期,净亏损同比有所改善。该行指,关键产品LZ901可能在2026财年第一季度末获得国内批准,这比该行此前预计的2025年第三季度末的期限有所推迟。因此,该行不再预计2025财年K3会带来收入。维持跑赢大市评级。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/ZmQ4YWNjMjZmNDUwZDg4ZTlkYjEwZTY1NmI3NmEzMzkwOTI4OTA5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZmQ4YWNjMjZmNDUwZDg4ZTlkYjEwZTY1NmI3NmEzMzkwOTI4OTA5.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1955521","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02480"],"gpt_icon":0},{"id":"2520649873","title":"綠竹生物-B公佈年度業績:虧損同比收窄32.5%,繼續專注於核心產品LZ901的研發工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2520649873","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520649873?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 17:47","pubTimestamp":1742291249,"startTime":"0","endTime":"0","summary":"截至2024年12月31日止年度,集团继续专注于核心产品LZ901的研发工作。根据III期临床试验的中期分析,LZ901的BLA已于2025年1月提交国家药监局,并随后于2025年2月获受理。国家药监局将进一步采取包括技术审评、临床试验现场核查、生产现场检查等程序以评核BLA,LZ901只有在获得BLA批准和批签发证明后方可进行商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318174744971ae1b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318174744971ae1b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2520643903","title":"綠竹生物-B(02480)發佈年度業績,稅前虧損1.68億元 同比減少32.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2520643903","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520643903?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 17:40","pubTimestamp":1742290837,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿竹生物-B 发布2024年年度业绩,该集团取得其他收入人民币2138.7万元,同比增加6.5%;研发开支1.35亿元,同比减少21.7%;税前亏损1.68亿元,同比减少32.5%;每股亏损0.83元。截至2024年12月31日止年度,本集团继续专注于核心产品LZ901的研发工作。LZ901在中国的III期临床试验的受试者入组已于2024年1月完成,共计26,000 名40岁及以上的健康受试者入组。根据III期临床试验的中期分析,LZ901的 BLA已于2025年1月提交国家药监局,并随后于2025年2月获受理。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1263487.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2519739948","title":"綠竹生物-B03月14日主力淨流入49萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2519739948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519739948?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 16:15","pubTimestamp":1741940118,"startTime":"0","endTime":"0","summary":"03月14日, 绿竹生物-B股价涨7.33%,报收24.90元,成交金额93万元,换手率0.02%,振幅7.97%,量比1.48。绿竹生物-B今日主力资金净流入49万元,上一交易日主力净流出0万元。该股近5个交易日上涨12.16%,主力资金累计净流入209万元;近20日主力资金累计净流入209万元,其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314164654a1dc79ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314164654a1dc79ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2519427588","title":"綠竹生物-B盤中異動 下午盤大幅上漲7.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519427588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519427588?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 15:21","pubTimestamp":1741936866,"startTime":"0","endTime":"0","summary":"2025年03月14日下午盘15时21分,绿竹生物-B股票出现波动,股价大幅上涨7.54%。绿竹生物-B股票所在的生物技术行业中,整体涨幅为2.49%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031415210698a7435e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031415210698a7435e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2519407005","title":"綠竹生物-B盤中異動 大幅下跌7.58%報22.550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2519407005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519407005?lang=zh_tw&edition=fundamental","pubTime":"2025-03-13 15:13","pubTimestamp":1741850029,"startTime":"0","endTime":"0","summary":"2025年03月13日下午盘15时13分,绿竹生物-B股票出现异动,股价大幅下跌7.58%。截至发稿,该股报22.550港元/股,成交量400股,换手率0.00%,振幅10.04%。资金方面,该股资金流入5000港元,流出4510港元。绿竹生物-B股票所在的生物技术行业中,整体跌幅为0.26%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031315135098a5ef51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031315135098a5ef51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2518562540","title":"綠竹生物-B盤中異動 快速下跌8.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518562540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518562540?lang=zh_tw&edition=fundamental","pubTime":"2025-03-12 14:57","pubTimestamp":1741762664,"startTime":"0","endTime":"0","summary":"2025年03月12日下午盘14时57分,绿竹生物-B股票出现波动,股价大幅跳水8.85%。绿竹生物-B股票所在的生物技术行业中,整体跌幅为0.74%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250312145744a1d7f2e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250312145744a1d7f2e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2518571320","title":"綠竹生物-B03月11日主力淨流入19萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518571320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518571320?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 16:16","pubTimestamp":1741680990,"startTime":"0","endTime":"0","summary":"03月11日, 绿竹生物-B股价涨6.58%,报收24.30元,成交金额102万元,换手率0.02%,振幅6.14%,量比32.87。绿竹生物-B今日主力资金净流入19万元,上一交易日主力净流出0万元。该股近5个交易日上涨15.99%,主力资金累计净流入19万元;近20日主力资金累计净流入19万元,其中净流入天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165944abf609cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165944abf609cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02480\",params:#limit:5,,,undefined,":[{"date":"2025-03-18","symbol":"02480","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742261400000,"name":null,"time":"盤後","dateTimestamp":1742227200000,"actualEps":null},{"date":"2024-08-21","symbol":"02480","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724203800000,"name":null,"time":"盤後","dateTimestamp":1724169600000,"actualEps":null},{"date":"2024-03-15","symbol":"02480","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710466200000,"name":null,"time":"","dateTimestamp":1710432000000,"actualEps":null},{"date":"2023-08-21","symbol":"02480","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692581400000,"name":null,"time":"","dateTimestamp":1692547200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02480\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02480\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1745251200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02480\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02480","date":"2025-05-16","current":-23.16559,"percent":0.370741,"low":-50.634384,"twenty":-34.958043,"median":-18.974865,"eighty":-14.042927,"high":-4.114514,"avg":-22.3555,"sd":11.296401,"marketCap":4220769672},"quantilePoints":[{"date":"2023-05-12","current":-5.074703,"twenty":-5.141932,"median":-4.426132,"eighty":-4.315282,"marketCap":4150205156},{"date":"2023-05-19","current":-6.276926,"twenty":-6.157049,"median":-5.438944,"eighty":-4.414,"marketCap":5061225800},{"date":"2023-05-25","current":-6.025537,"twenty":-6.282911,"median":-5.817621,"eighty":-4.815275,"marketCap":4838531864},{"date":"2023-06-02","current":-7.108523,"twenty":-6.788873,"median":-6.18905,"eighty":-5.276391,"marketCap":5688817799},{"date":"2023-06-09","current":-8.132145,"twenty":-7.304397,"median":-6.309111,"eighty":-5.444563,"marketCap":6498613927},{"date":"2023-06-16","current":-8.09491,"twenty":-8.243136,"median":-6.773271,"eighty":-5.552638,"marketCap":6437879217},{"date":"2023-06-23","current":-7.99853,"twenty":-8.19132,"median":-7.057928,"eighty":-5.776037,"marketCap":6326532250},{"date":"2023-06-30","current":-10.22826,"twenty":-8.355382,"median":-7.314546,"eighty":-6.074942,"marketCap":8016981667},{"date":"2023-07-07","current":-8.773125,"twenty":-8.461217,"median":-7.999898,"eighty":-6.165049,"marketCap":6863022184},{"date":"2023-07-14","current":-8.064731,"twenty":-8.488591,"median":-8.098962,"eighty":-6.2242,"marketCap":6397389411},{"date":"2023-07-21","current":-8.217769,"twenty":-8.461217,"median":-8.132145,"eighty":-6.282911,"marketCap":6488491475},{"date":"2023-07-28","current":-8.419084,"twenty":-8.421723,"median":-8.150258,"eighty":-6.305666,"marketCap":6640328249},{"date":"2023-08-04","current":-8.302611,"twenty":-8.433084,"median":-8.175239,"eighty":-6.384674,"marketCap":6559348636},{"date":"2023-08-11","current":-8.233788,"twenty":-8.421723,"median":-8.173568,"eighty":-6.59262,"marketCap":6468246572},{"date":"2023-08-18","current":-8.371035,"twenty":-8.447732,"median":-8.198547,"eighty":-6.788873,"marketCap":6528981282},{"date":"2023-08-25","current":-36.775961,"twenty":-8.488591,"median":-8.22448,"eighty":-6.910536,"marketCap":6032981153},{"date":"2023-09-01","current":-50.634384,"twenty":-8.532708,"median":-8.24341,"eighty":-7.078166,"marketCap":8340900118},{"date":"2023-09-08","current":-38.241641,"twenty":-8.777665,"median":-8.259865,"eighty":-7.170634,"marketCap":6225307734},{"date":"2023-09-15","current":-42.575145,"twenty":-36.451658,"median":-8.302611,"eighty":-7.304397,"marketCap":6984491604},{"date":"2023-09-22","current":-47.100298,"twenty":-37.976001,"median":-8.354776,"eighty":-7.575971,"marketCap":7693063216},{"date":"2023-09-29","current":-43.864392,"twenty":-38.642311,"median":-8.372129,"eighty":-7.934606,"marketCap":7176818184},{"date":"2023-10-06","current":-42.833147,"twenty":-39.549549,"median":-8.411287,"eighty":-7.998804,"marketCap":7004736507},{"date":"2023-10-13","current":-42.773246,"twenty":-40.772579,"median":-8.427902,"eighty":-8.012865,"marketCap":6984491604},{"date":"2023-10-20","current":-41.038761,"twenty":-42.472898,"median":-8.45323,"eighty":-8.070767,"marketCap":6690940507},{"date":"2023-10-27","current":-43.478764,"twenty":-42.528314,"median":-8.467479,"eighty":-8.09491,"marketCap":7085716120},{"date":"2023-11-03","current":-43.115829,"twenty":-42.671946,"median":-8.490236,"eighty":-8.096666,"marketCap":7045226313},{"date":"2023-11-10","current":-40.274636,"twenty":-42.575145,"median":-8.527418,"eighty":-8.103013,"marketCap":6579593540},{"date":"2023-11-17","current":-41.142791,"twenty":-42.528314,"median":-8.744908,"eighty":-8.132145,"marketCap":6782042572},{"date":"2023-11-24","current":-41.415901,"twenty":-42.502629,"median":-8.780691,"eighty":-8.13418,"marketCap":6883267088},{"date":"2023-12-01","current":-40.638335,"twenty":-42.482551,"median":-23.319225,"eighty":-8.138547,"marketCap":6782042572},{"date":"2023-12-08","current":-36.540226,"twenty":-42.364281,"median":-36.540226,"eighty":-8.16086,"marketCap":6073470960},{"date":"2023-12-15","current":-31.365274,"twenty":-42.353974,"median":-36.444746,"eighty":-8.166335,"marketCap":5243429928},{"date":"2023-12-22","current":-36.354714,"twenty":-42.222786,"median":-35.228598,"eighty":-8.171278,"marketCap":6073470960},{"date":"2023-12-29","current":-36.041365,"twenty":-42.205507,"median":-36.198039,"eighty":-8.171649,"marketCap":6053226056},{"date":"2024-01-05","current":-37.632709,"twenty":-42.186199,"median":-36.19804,"eighty":-8.173234,"marketCap":6275919992},{"date":"2024-01-12","current":-35.792717,"twenty":-42.165268,"median":-36.401933,"eighty":-8.177335,"marketCap":5972246444},{"date":"2024-01-19","current":-34.566218,"twenty":-41.985044,"median":-36.261145,"eighty":-8.187707,"marketCap":5759674960},{"date":"2024-01-26","current":-34.945217,"twenty":-41.702629,"median":-35.889121,"eighty":-8.200201,"marketCap":5800164766},{"date":"2024-02-02","current":-34.134928,"twenty":-41.702629,"median":-35.510658,"eighty":-8.208717,"marketCap":5658450444},{"date":"2024-02-09","current":-34.696826,"twenty":-41.629046,"median":-35.173968,"eighty":-8.223137,"marketCap":5779919863},{"date":"2024-02-16","current":-34.021056,"twenty":-41.592669,"median":-35.129341,"eighty":-8.23119,"marketCap":5668572896},{"date":"2024-02-23","current":-29.437593,"twenty":-41.560591,"median":-34.945217,"eighty":-8.233788,"marketCap":4879021671},{"date":"2024-03-01","current":-26.855742,"twenty":-41.552583,"median":-34.827443,"eighty":-8.24341,"marketCap":4453878704},{"date":"2024-03-08","current":-23.915389,"twenty":-41.5498,"median":-34.696826,"eighty":-8.246673,"marketCap":3968001027},{"date":"2024-03-15","current":-22.959574,"twenty":-41.415901,"median":-34.547961,"eighty":-8.257826,"marketCap":3806041801},{"date":"2024-03-22","current":-13.452398,"twenty":-41.280844,"median":-34.159277,"eighty":-8.261904,"marketCap":3644082576},{"date":"2024-03-28","current":-13.495561,"twenty":-41.170402,"median":-34.134928,"eighty":-8.27397,"marketCap":3644082576},{"date":"2024-04-05","current":-14.119656,"twenty":-41.102561,"median":-34.049221,"eighty":-8.287236,"marketCap":3810090782},{"date":"2024-04-12","current":-14.54654,"twenty":-41.040833,"median":-33.902332,"eighty":-8.321936,"marketCap":3927511220},{"date":"2024-04-19","current":-15.384478,"twenty":-40.998673,"median":-33.006233,"eighty":-8.351253,"marketCap":4150205156},{"date":"2024-04-26","current":-21.264303,"twenty":-40.932898,"median":-32.88325,"eighty":-8.354171,"marketCap":5729307605},{"date":"2024-05-03","current":-25.197419,"twenty":-40.921141,"median":-31.75475,"eighty":-8.360451,"marketCap":5466123864},{"date":"2024-05-10","current":-24.951534,"twenty":-40.901135,"median":-31.289029,"eighty":-8.371254,"marketCap":5425634057},{"date":"2024-05-17","current":-23.216659,"twenty":-40.873797,"median":-30.477756,"eighty":-8.372129,"marketCap":5040980896},{"date":"2024-05-24","current":-22.335273,"twenty":-40.869522,"median":-29.437593,"eighty":-8.398215,"marketCap":4838531864},{"date":"2024-05-31","current":-18.671602,"twenty":-40.638335,"median":-26.493199,"eighty":-8.411287,"marketCap":4048980640},{"date":"2024-06-07","current":-18.489144,"twenty":-40.367709,"median":-25.801624,"eighty":-8.419084,"marketCap":4004441852},{"date":"2024-06-14","current":-18.89905,"twenty":-40.350491,"median":-25.653838,"eighty":-8.422603,"marketCap":4089470446},{"date":"2024-06-21","current":-21.188839,"twenty":-40.288946,"median":-25.229843,"eighty":-8.430554,"marketCap":4575348123},{"date":"2024-06-28","current":-20.587968,"twenty":-40.108586,"median":-24.951534,"eighty":-8.438052,"marketCap":4443756252},{"date":"2024-07-05","current":-20.873885,"twenty":-40.009541,"median":-23.915389,"eighty":-8.447732,"marketCap":4504490962},{"date":"2024-07-12","current":-22.529465,"twenty":-39.85132,"median":-23.456349,"eighty":-8.458254,"marketCap":4868899219},{"date":"2024-07-19","current":-22.508759,"twenty":-39.66272,"median":-23.163847,"eighty":-8.465129,"marketCap":4864515374},{"date":"2024-07-26","current":-21.823109,"twenty":-39.542312,"median":-22.952784,"eighty":-8.478815,"marketCap":4733856903},{"date":"2024-08-02","current":-21.186785,"twenty":-39.436158,"median":-22.899165,"eighty":-8.488591,"marketCap":4593147781},{"date":"2024-08-09","current":-20.539925,"twenty":-39.267163,"median":-22.755777,"eighty":-8.490269,"marketCap":4482590613},{"date":"2024-08-16","current":-20.900232,"twenty":-38.975641,"median":-22.694782,"eighty":-8.502601,"marketCap":4562995826},{"date":"2024-08-23","current":-15.034988,"twenty":-38.826209,"median":-22.519112,"eighty":-8.520744,"marketCap":4593147781},{"date":"2024-08-30","current":-14.248445,"twenty":-38.553098,"median":-22.372848,"eighty":-8.532708,"marketCap":4382084097},{"date":"2024-09-06","current":-14.045602,"twenty":-38.373279,"median":-22.224227,"eighty":-8.647314,"marketCap":4321780188},{"date":"2024-09-13","current":-14.377214,"twenty":-38.293924,"median":-21.962109,"eighty":-8.749616,"marketCap":4412236052},{"date":"2024-09-20","current":-13.933408,"twenty":-38.214918,"median":-21.716284,"eighty":-8.770319,"marketCap":4301678884},{"date":"2024-09-27","current":-15.500476,"twenty":-38.019583,"median":-21.523409,"eighty":-8.776151,"marketCap":4814262116},{"date":"2024-10-04","current":-15.018573,"twenty":-37.764917,"median":-21.40631,"eighty":-8.824208,"marketCap":4643401039},{"date":"2024-10-10","current":-16.1962,"twenty":-37.677753,"median":-21.326372,"eighty":-8.998274,"marketCap":4975072542},{"date":"2024-10-18","current":-17.234936,"twenty":-37.667079,"median":-21.233145,"eighty":-10.22826,"marketCap":5266541438},{"date":"2024-10-25","current":-15.755835,"twenty":-37.632709,"median":-21.13539,"eighty":-13.11092,"marketCap":4814262116},{"date":"2024-11-01","current":-16.106802,"twenty":-37.40391,"median":-21.038608,"eighty":-13.302926,"marketCap":4924819284},{"date":"2024-11-08","current":-14.308698,"twenty":-37.309147,"median":-20.990417,"eighty":-13.452398,"marketCap":4341881491},{"date":"2024-11-15","current":-14.150671,"twenty":-37.266259,"median":-20.950887,"eighty":-13.495561,"marketCap":4261476278},{"date":"2024-11-22","current":-13.925064,"twenty":-37.125428,"median":-20.910512,"eighty":-13.515744,"marketCap":4191121717},{"date":"2024-11-29","current":-14.868539,"twenty":-37.119062,"median":-20.873885,"eighty":-13.591232,"marketCap":4472539962},{"date":"2024-12-06","current":-14.903644,"twenty":-37.083223,"median":-20.741791,"eighty":-13.638824,"marketCap":4472539962},{"date":"2024-12-13","current":-17.196727,"twenty":-37.024117,"median":-20.632031,"eighty":-13.7104,"marketCap":5155984270},{"date":"2024-12-20","current":-15.705551,"twenty":-36.775961,"median":-20.444203,"eighty":-13.755213,"marketCap":4683044445},{"date":"2024-12-27","current":-14.975706,"twenty":-36.759538,"median":-20.147116,"eighty":-13.762915,"marketCap":4461956510},{"date":"2025-01-03","current":-14.961058,"twenty":-36.698715,"median":-19.723631,"eighty":-13.769631,"marketCap":4461956510},{"date":"2025-01-10","current":-13.529695,"twenty":-36.590433,"median":-19.407269,"eighty":-13.769631,"marketCap":4019780640},{"date":"2025-01-17","current":-15.445213,"twenty":-36.515856,"median":-18.99261,"eighty":-13.802468,"marketCap":4592599381},{"date":"2025-01-24","current":-15.416209,"twenty":-36.451658,"median":-18.88953,"eighty":-13.864251,"marketCap":4612698284},{"date":"2025-01-28","current":-16.178623,"twenty":-36.424013,"median":-18.775806,"eighty":-13.880338,"marketCap":4863934574},{"date":"2025-02-07","current":-16.263139,"twenty":-36.403585,"median":-18.459002,"eighty":-13.90509,"marketCap":4863934574},{"date":"2025-02-14","current":-14.752701,"twenty":-36.366396,"median":-18.399312,"eighty":-13.910841,"marketCap":4401659800},{"date":"2025-02-21","current":-15.040713,"twenty":-36.355274,"median":-18.348745,"eighty":-13.922298,"marketCap":4512203768},{"date":"2025-02-28","current":-13.981349,"twenty":-36.205004,"median":-18.003871,"eighty":-13.922298,"marketCap":4180571865},{"date":"2025-03-07","current":-14.862727,"twenty":-36.066607,"median":-17.630273,"eighty":-13.931739,"marketCap":4461956510},{"date":"2025-03-14","current":-16.664293,"twenty":-35.91957,"median":-17.25119,"eighty":-13.952205,"marketCap":5004626896},{"date":"2025-03-21","current":-27.850982,"twenty":-35.811998,"median":-17.265054,"eighty":-13.961209,"marketCap":5024725800},{"date":"2025-03-28","current":-27.851641,"twenty":-35.341422,"median":-17.666035,"eighty":-13.977536,"marketCap":5014676348},{"date":"2025-04-03","current":-27.730368,"twenty":-35.205527,"median":-18.003871,"eighty":-13.985669,"marketCap":4994577445},{"date":"2025-04-11","current":-27.811891,"twenty":-35.180439,"median":-18.348745,"eighty":-13.99053,"marketCap":4964429090},{"date":"2025-04-17","current":-27.831311,"twenty":-35.17174,"median":-18.396379,"eighty":-13.991851,"marketCap":4974478542},{"date":"2025-04-25","current":-27.496924,"twenty":-35.152775,"median":-18.437994,"eighty":-13.995129,"marketCap":4924231284},{"date":"2025-05-02","current":-24.638746,"twenty":-35.090285,"median":-18.489144,"eighty":-14.008243,"marketCap":4421758704},{"date":"2025-05-09","current":-23.799704,"twenty":-35.025533,"median":-18.880009,"eighty":-14.027432,"marketCap":4301165284},{"date":"2025-05-16","current":-23.16559,"twenty":-34.958043,"median":-18.974865,"eighty":-14.042927,"marketCap":4220769672}],"updateTime":1747469652258}}}